Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis
Status:
Active, not recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if adding cidofovir to the standard of
care can improve symptoms of hemorrhagic cystitis caused by the BK virus as compared to
standard of care alone. The safety of cidofovir will also be studied.